Market Dynamics: The germ cell tumor market is anticipated to demonstrate a robust compound annual growth rate (CAGR) in revenue during the forecast period. The primary drivers of market revenue growth include the increasing prevalence of cancer, substantial healthcare investments by major players, and a significant surge in public awareness. […]